Neurology: Thought Leaders
Professor Stefan Schwab of Germany, Professor Jacques De Reuck of Belgium and Professor Kurt Jellinger of Austria are among the foremost thought leaders in the field of neurology in Europe. These and other findings are outlined below.
Euro Neurology 2020
- The Euro Neurology and Neurosurgery Congress is the leading conference for neurology and neurosurgeons in Europe.
- Euro Neurology 2020 targets neurologists, neurosurgeons, neuroscientists, neuroradiologists, neuro-oncologists, students, researchers, scholars, professors, business partners and other professionals in the field.
- The conference will be held in Paris this March 26-27, 2020.
- The conference features the foremost thought leaders and experts in the fields as keynote speakers.
- The neurology thought leaders outlined below are the primary speakers in the Euro Neurology 2020 conference.
- Stefan Schwab is Professor of Neurology as well as Director and Chair of the Department of Neurology at Friedrich-Alexander University Erlangen-Nuremberg in Germany.
- He is also President of the European Stroke Research Network for Hypothermia (EuroHYP), German Neurocritical Care Society, and a founding member of the American Neurocritical Care Society.
- He has received numerous national and international awards for his groundbreaking research on stroke.
- Professor Schwab has written and co-authored over 200 publications on neurological and cerebrovascular diseases in scientific journals including Stroke, the European Journal of Neurology, Experimental Neurology and others.
- Professor Schwab's main research interests include stroke diagnostics, MRI, cerebral ischaemia, brain lesions, neuroprotection and pharmacokinetics among others.
- His recent work in the past 2 years was focused on advancing understanding and treatment of ischemic stroke.
- In April 2019, he co-authored the study "Therapeutic Hypothermia for Acute Ischaemic Stroke" published in the European Stroke Journal.
- He also co-authored the paper "Heart Failure in Ischemic Stroke" and its relevance for acute care published in the American Heart Association journal last September 2019.
- Professor Schwab recently co-authored the results of a 120-case study of idarucizumab in treatment of ischemic stroke published in the International Journal of Stroke this January 2020.
Jacques De Reuck
- Jacques De Reuck is Professor on Degenerative and Vascular Cognitive Disorders at the Université de Lille 2 in France.
- Professor De Reuck is current chairman and past President of the Congress Programme Committee of the European Federation of Neurological Societies (EFNS).
- He is also a founding member of the European Task Force on Age-Related White Matter Changes.
- He is a principal investigator in the Stroke and Atrial Fibrillation Ensemble (SAFE) II study as well as the Piracetam Acute Stroctorke Study (PASS).
- Professor De Reuck's research interests include stroke management and treatment, epilepsy and Parkinson's disease among others.
- Professor De Reuck has written over 500 peer-reviewed publications.
- His recent work in the past 2 years was focused on aging.
- He is the primary author of the paper " Aging And Cerebrovascular Lesion In Pure And In Mixed Neurodegenerative And Vascular Dementia Brains" published in Neuropathologica in 2018.
- Professor De Reuck has also published the study "Iron Deposition in the Brain during the Aging Process and in Neurodegenerative Diseases" in ECronicon last December 2019.
- Professor De Reuck has also spoken about brain lesions in the recent Neurovascular and Neurodegenerative Diseases international conference last October 2019.
Kurt A Jellinger
- Kurt Jellinger is Professor and Director of the Institute of Clinical Neurobiology as well as Professor of Neurology and Neuropathology at the Medical University in Austria.
- He has also served as the past Director of the Department of Neurology at Lainz Hospital in Vienna as well as the Ludwig Boltzmann Institute of Clinical Neurobiology.
- He has published over 1,000 papers in peer-reviewed journals, contributed to 170 scientific books, and gave 1,300 lectures at international meetings and conferences.
- Professor Jellinger has received numerous grants and awards for his work and served as editor of several journals covering neurology, neuroscience and neuropathology.
- Professor Jellinger's recent work in the past 2 years was focused on advancing understanding and treatment of neurodegenerative diseases.
- He has authored the paper "Proteomics For Synaptic Markers Of Cognitive Decline In Neurodegenerative Diseases" published in BRAIN on January 2018.
- He has also written "Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy" for the Journal of Alzheimers Disease's 20th anniversary issue on March 2018.
- Professor Jellinger has also spoken at the previous Brain Disorders and Therapeutics International Conference.